Vasculitis in New Zealand
Related Experiment Video
Updated: May 16, 2026

In Vivo Imaging and Quantitation of the Host Angiogenic Response in Zebrafish Tumor Xenografts
Published on: August 14, 2019
1Department of Renal Medicine, North Shore Hospital, Waitemata District Health Board, 122 Shakespeare Road, Takapuna, Auckland, 0740, New Zealand. janak.dezoysa@waitematadhb.govt.nz.
Background:
The Asia Pacific Meeting for Vasculitis and ANCA Workshop was held in Tokyo in May 2012. This review of vasculitis in New Zealand (NZ) was prepared for the meeting.
Methods:
A review of significant NZ demographic and health data is presented with information from relevant studies on vasculitis originating from NZ.
Results:
Giant cell arteritis occurs in older adults, and has an annual incidence of 12.7/100,000 adults over the age of 50 years in NZ. Kawasaki disease, a rare cause of acquired cardiac disease primarily affecting young children, has an annual incidence of 8.0/100,000 children aged less than 5 years. The prevalence of granulomatosis with polyangiitis varies within NZ, with a 5-year prevalence varying from 29 to 75 cases per million people. Dual anti-glomerular basement membrane disease and ANCA-associated systemic vasculitis is rare, with an annual incidence estimated at 0.47 cases per million people.
Conclusions:
Vasculitis is an uncommon but a significant cause of morbidity and mortality in NZ.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Endocarditis I: Introduction
